Cargando…
Diversifying Isoprenoid Platforms via Atypical Carbon Substrates and Non-model Microorganisms
Isoprenoid compounds are biologically ubiquitous, and their characteristic modularity has afforded products ranging from pharmaceuticals to biofuels. Isoprenoid production has been largely successful in Escherichia coli and Saccharomyces cerevisiae with metabolic engineering of the mevalonate (MVA)...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677530/ https://www.ncbi.nlm.nih.gov/pubmed/34925299 http://dx.doi.org/10.3389/fmicb.2021.791089 |